Early Intervention for Premyopic Children
Early Intervention for Premyopic Children: A Comparison Study of Defocus Integrated Multiple Segments Spectacle Lenses, 0.01% Atropine and Usual Care for Myopia Prevention
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Phase 2
Contacts and Locations
Study Contact
Study Contact
- Name: Der-Chong Tsai, MD, PhD
- Phone Number: 12861 +886 3 9325192
- Email: tsai5969@gmail.com
Study Locations
-
-
-
Yilan, Taiwan, 26058
- National Yang Ming Chiao Tung University Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age at enrollment: 5-6 years old (the senior grade of kindergarten)
- Cycloplegic SE of the eye with less SE (less positive or more negative refractive error): < +1.00 D and > -0.50 D
- Astigmatism: 1.0 D or less in both eyes
- Anisometropia: 1.50 D or less
- Monocular uncorrected visual acuity: 6/7.5 or better in both eyes
- Either of the parents with moderate myopia
- Acceptance of random group allocation
- Submission of complete informed consent.
Exclusion Criteria:
- Strabismus or any ocular motility disorder
- Any ophthalmic and systemic disorders that might affect visual functions or refractive development
- Previous treatment of atropine or other myopia control intervention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: DIMS lens
DIMS spectacle lenses.
Daily wear for 1.5 years.
|
No power in the central optic zone of DIMS lens for premyopic children with normal vision.
Before entering elementary school, eligible preschoolers are asked to wear the DIMS spectacles after kindergarten hours and during weekends and holidays.
After entering elementary school, full-time mode wearing of DIMS spectacles is required.
Other Names:
|
|
Experimental: 0.01% Atropine
0.01% Atropine.
One drop per eye, per day, for 1.5 years.
|
daily use of non-preservative 0.01% atropine eye drop for each eye over the study period.
Other Names:
|
|
No Intervention: Usual care
Usual care including promoting outdoor time
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Myopic shift of spherical equivalent refraction
Time Frame: 18 months
|
The change of mean cycloplegic spherical equivalent refraction over 1.5 years
|
18 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Axial length elongation
Time Frame: 18 months
|
The change of mean axial length over 1.5 years
|
18 months
|
|
Incidence of myopia
Time Frame: 18 months
|
the cumulative percentage of incident myopia
|
18 months
|
|
Fast myopic shift of spherical equivalent refraction
Time Frame: 18 months
|
the cumulative percentage of fast myopic shift of spherical equivalent refraction
|
18 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Der-Chong Tsai, MD, PhD, National Yang Ming Chiao Tung University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Eye Diseases
- Refractive Errors
- Myopia
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Autonomic Agents
- Peripheral Nervous System Agents
- Neurotransmitter Agents
- Anti-Arrhythmia Agents
- Adjuvants, Anesthesia
- Respiratory System Agents
- Anti-Asthmatic Agents
- Bronchodilator Agents
- Muscarinic Antagonists
- Cholinergic Antagonists
- Cholinergic Agents
- Parasympatholytics
- Mydriatics
- Atropine
Other Study ID Numbers
Other Study ID Numbers
- NYCUH2023A018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.